Biotech · Private company
Xeris Pharmaceuticals
Track this companyFree. Adds Xeris Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- G-PenPhase 3 · Insulin HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- Lilly GlucagonPhase 3 · Insulin HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- Novo GlucagonPhase 3 · Insulin HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- GlucagonPhase 2 · Hypoglycemia UnawarenessClinicalTrials.gov · fetched Nov 12, 2026
- GlucagonPhase 2 · Congenital HyperinsulinismClinicalTrials.gov · fetched Nov 12, 2026
- Glucagon RTUPhase 2 · Hyperinsulinemic HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- levothyroxine sodiumPhase 2 · HypothyroidismClinicalTrials.gov · fetched Nov 12, 2026
- PRAM9Phase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Regular InsulinPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Regular Insulin + PramlintidePhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Study of XP-8121 For the Treatment of Adult Subjects With HypothyroidismPHASE2 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05823012 · fetched Nov 12, 2026
- Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1DPHASE2 · COMPLETED · started Aug 22, 2019ClinicalTrials.gov NCT04074317 · fetched Nov 12, 2026
- Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric SurgeryPHASE2 · COMPLETED · started May 10, 2019ClinicalTrials.gov NCT03770637 · fetched Nov 12, 2026
- G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesPHASE3 · COMPLETED · started Sep 27, 2018ClinicalTrials.gov NCT03738865 · fetched Nov 12, 2026
- Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory ResponsesPHASE2 · TERMINATED · started Mar 15, 2018ClinicalTrials.gov NCT03490942 · fetched Nov 12, 2026
- G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 DiabetesPHASE3 · COMPLETED · started Jan 23, 2018ClinicalTrials.gov NCT03439072 · fetched Nov 12, 2026
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric HypoglycemiaPHASE1_PHASE2 · COMPLETED · started Sep 19, 2017ClinicalTrials.gov NCT03255629 · fetched Nov 12, 2026
- CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital HyperinsulinismPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02937558 · fetched Nov 12, 2026